Stoke Therapeutics (STOK)
Develops antisense medicines that restore protein expression in severe genetic diseases.
$26.63
vs last close−2.57 (−8.80%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 118.68% | 76.58M shares | |
|---|---|---|---|
| 203 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.78% | 505.2K shares | |
| 8 holders · as of Sep 3, 2026 | |||
| Adds to | 119.46% | ||
64.53M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 119.46%; nothing is left for Other.
13F, as of Jun 30, 2026
203 holders · 76.58M shares · 34 new positions · 110 increased · 58 reduced · 31 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.88M | 9.11% | +491.6K | Aug 7, 2026 |
| RTW Investments, LP | 5.62M | 8.72% | 0 | Aug 14, 2026 |
| FMR LLC | 5.31M | 8.23% | −70.6K | Aug 13, 2026 |
| LYNX1 Capital Management LP | 4.04M | 6.26% | −725.3K | Aug 13, 2026 |
| Redmile Group, LLC | 3.95M | 6.12% | −218.2K | Aug 14, 2026 |
| Wellington Management Group LLP | 3.52M | 5.45% | +423.6K | Aug 14, 2026 |
| Morgan Stanley | 3.45M | 5.35% | +29.5K | Aug 13, 2026 |
| Baker Bros. Advisors LP | 3.34M | 5.17% | 0 | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| RTW Investments, LP | 9.90% | 5.94M | 13G | May 15, 2026 |
| FMR LLC | 9.80% | 5.60M | 13G | Feb 5, 2026 |
| Baker Bros. Advisors (GP) LLCincl. Felix J. Baker, Julian C. Baker +1 more | 8.30% | 4.37M | 13G | Nov 14, 2024 |
| Lynx1 Capital Management LP | 8.10% | 4.76M | 13G | May 18, 2026 |
| BlackRock, Inc. | 6.80% | 3.73M | 13G | Oct 17, 2025 |
| Redmile Group, LLC | 6.70% | 4.16M | 13G | May 15, 2026 |
| Morgan Stanley | 6.50% | 3.43M | 13G | Feb 3, 2025 |
| Baker Bros. Advisors LP | 5.80% | 3.34M | 13G | Feb 17, 2026 |
| The Toronto-Dominion Bank | 5.40% | 3.17M | 13G | May 15, 2026 |
| Wellington Management Group LLP | 5.20% | 3.10M | 13G | May 15, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 1, 2026 | Barry Tichoofficer: CHIEF MEDICAL OFFICER | Sale · 2 lots | 5,545 | $30.67 | 20,110 |
| Aug 18, 2026 | Edward M. MD Kayedirector | Sale · 2 lots | 12,567 | $32.03 | 124,557 |
| Aug 18, 2026 | Barry Tichoofficer: CHIEF MEDICAL OFFICER | Sale · 2 lots | 4,767 | $32.03 | 25,655 |
| Aug 18, 2026 | Jonathan Allanofficer: GENERAL COUNSEL & CORP SEC | Sale · 2 lots | 2,861 | $32.03 | 21,225 |
| Aug 3, 2026 | Barry Tichoofficer: CHIEF MEDICAL OFFICER | Sale · 2 lots | 7,176 | $29.04 | 20,422 |
| Jul 1, 2026 | Barry Tichoofficer: CHIEF MEDICAL OFFICER | Sale · 2 lots | 7,228 | $32.66 | 27,598 |
| Jun 16, 2026 | Jonathan Allanofficer: GENERAL COUNSEL & CORP SEC | Sale | 1,457 | $29.95 | 18,086 |
| Jun 1, 2026 | Barry Tichoofficer: CHIEF MEDICAL OFFICER | Sale | 1,795 | $30.58 | 34,826 |
| May 1, 2026 | Barry Tichoofficer: CHIEF MEDICAL OFFICER | Sale | 2,243 | $32.79 | 36,621 |
| Apr 1, 2026 | Barry Tichoofficer: CHIEF MEDICAL OFFICER | Sale | 1,838 | $32.66 | 38,864 |
House and Senate disclosures
Not reported.